These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6569602)

  • 1. Getting essential drugs to the people.
    Kingma S
    Philipp J Nurs; 1983; 53(2):32-6. PubMed ID: 6569602
    [No Abstract]   [Full Text] [Related]  

  • 2. Essential drugs should be accessible to all people.
    Habiyambere V; Wertheimer AI
    World Health Forum; 1993; 14(2):140-4. PubMed ID: 8185754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential drugs for developing countries.
    Ceylon Med J; 1978; 23(2-3):41-4. PubMed ID: 263408
    [No Abstract]   [Full Text] [Related]  

  • 4. Use caution when donating drugs, guidelines suggest.
    Riggs B
    CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug donations to developing countries.
    Khare AK
    World Hosp Health Serv; 2001; 37(1):18-9, 33-4. PubMed ID: 11372253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of essential drugs. Third report of the WHO Expert Committee.
    Bull Int Union Tuberc Lung Dis; 1989 Jun; 64(2):45-6. PubMed ID: 2790287
    [No Abstract]   [Full Text] [Related]  

  • 7. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 9. Substandard and counterfeit drugs in developing countries.
    Behrens RH; Awad AI; Taylor RB
    Trop Doct; 2002 Jan; 32(1):1-2. PubMed ID: 11991013
    [No Abstract]   [Full Text] [Related]  

  • 10. Getting the upper hand on expired drugs.
    Wick JY
    Consult Pharm; 2010 Feb; 25(2):122-4. PubMed ID: 20211825
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of essential drugs and primary health care. What are the important next steps?
    Lohse AW; Vaughan JP
    J Trop Med Hyg; 1983 Aug; 86(4):131-7. PubMed ID: 6668633
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of substandard drugs in developing countries.
    Afu S
    Trop Med Int Health; 1999 Jan; 4(1):73. PubMed ID: 10203177
    [No Abstract]   [Full Text] [Related]  

  • 13. Better access to drugs in developing countries is accelerating resistance.
    Mayor S
    BMJ; 2010 Jun; 340():c3234. PubMed ID: 20558519
    [No Abstract]   [Full Text] [Related]  

  • 14. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doha Declaration has failed to deliver cheap drugs to developing countries, Oxfam says.
    O'Dowd A
    BMJ; 2006 Nov; 333(7577):1036. PubMed ID: 17110708
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for the poor of the Third World: consumption and distribution.
    Mills A; Walker GJ
    J Trop Med Hyg; 1983 Aug; 86(4):139-45. PubMed ID: 6668634
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs in the home: danger and waste.
    Kiyingi KS; Lauwo JA
    World Health Forum; 1993; 14(4):381-4. PubMed ID: 8185788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential drugs in the Gambia.
    Jallow MT
    World Health Forum; 1993; 14(2):136-9. PubMed ID: 8185753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.